Please use this identifier to cite or link to this item: http://hdl.handle.net/10668/3129
Título : Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial
Autor : Maldonado, J.
Gil-Campos, M.
Maldonado-Lobón, J.A.
Benavides, M.R.
Flores-Rojas, K.
Jaldo, R.
Jiménez Del Barco, I.
Bolívar, V.
Valero, A.D.
Prados, E.
Peñalver, I.
Olivares, M.
Filiación: [Maldonado,J] Pediatric Unit, University Hospital Virgen de las Nieves, Granada, Spain. [Maldonado,J] Pediatric Department, University of Granada, Granada, Spain. [Maldonado,J] Biosanitary Research Institute (IBS), Granada, Spain. [Maldonado,J] Maternal and Child Health and Development Network (SAMID), Health Institute Carlos III, Madrid, Spain. [Gil-Campos,M; Flores-Rojas,K] Unit of Metabolism and Pediatric Research (IMIBIC), Reina Sofia University Hospital, University of Córdoba, Cordoba, Spain. [Gil-Campos,M] CIBEROBN, Cordoba, Spain. [Maldonado-Lobón,JA; Valero,AD] Biosearch Life, Research Department, Granada, Spain. [Benavides,MR] Pediatric Clinic Roquetas, Roquetas de Mar, Almería, Spain. [Jaldo,R; Bolívar,V; Prados,E; Peñalver,I] Andalusian Health Service, Andalusia, Spain. [Jiménez Del Barco,I] Clinic "Cristo de la Salud" Albolote, Granada, Spain. [Olivares,M] Biosearch Life, Research Department, Granada, Spain.
Palabras clave : Infant formula
Probiotics
Safety
Diarrhea
Colic
Fórmulas infantiles
Probióticos
Seguridad
Diarrea
Cólico
Lactante
MeSH: Medical Subject Headings::Technology and Food and Beverages::Food and Beverages::Beverages::Milk Substitutes::Infant Formula
Medical Subject Headings::Technology and Food and Beverages::Food and Beverages::Food::Dietary Supplements::Probiotics
Medical Subject Headings::Persons::Persons::Age Groups::Infant
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Diarrhea
Medical Subject Headings::Health Care::Environment and Public Health::Public Health::Accidents::Accident Prevention::Safety
Medical Subject Headings::Diseases::Pathological Conditions, Signs and Symptoms::Signs and Symptoms::Signs and Symptoms, Digestive::Abdominal Pain::Colic
Fecha de publicación : 21-Oct-2019
Editorial : BioMed Central
Cita Bibliográfica: Maldonado Lozano J, Gil Campos M, Maldonado Lobón JA, Benavides MR, Flores-Rojas K, Jaldo R, et al. Evaluation of the safety, tolerance and efficacy of 1-year consumption of infant formula supplemented with Lactobacillus fermentum CECT5716 Lc40 or Bifidobacterium breve CECT7263: a randomized controlled trial. BMC Pediatr. 2019;19(1):361.
Abstract: Background: The microorganism present in breast milk, added to other factors, determine the colonization of infants. The objective of the present study is to evaluate the safety, tolerance and effects of the consumption of a milk formula during the first year of life that is supplemented with L. fermentum CECT5716 or Bifidobacterium breve CECT7263, two strains originally isolated from breast milk. Methods: A randomized, double blind, controlled, parallel group study including healthy, formula-fed infants was conducted. Two hundred and thirty-six 1-month-old infants were selected and randomly divided into three study groups according to a randomization list. Infants in the control group received a standard powdered infant formula until 12 months of age. Infants in the probiotic groups received the same infant formula but supplemented with L. fermentum CECT5716 Lc40 or B. breve CECT7263. Main outcome was weigh-gain of infants as safety marker. Results: One hundred and eighty-nine infants completed the eleven months of intervention (61 in control group, 65 in Lf group and 63 in Bb group). The growth of infants in the three groups was consistent with standards. No significant differences were observed in the main outcome, weight-gain (Control group: 5.77 Kg ± 0.95, Lf group: 5.77 Kg ± 1.31, Bb group: 5.58 Kg ± 1.10; p = 0.527). The three milk formulae were well tolerated, and no adverse effects were related to the consumption of any of the formula. Infants receiving B. breve CECT7263 had a 1.7 times lower risk of crying than the control group (OR = 0.569, CI 95% 0.568-0.571; p = 0.001). On the other hand, the incidence of diarrhoea in infants receiving the formula supplemented with L. fermentum CECT5716 was a 44% lower than in infants receiving the control formula (p = 0.014). The consumption of this Lactobacillus strain also reduced the duration of diarrhoea by 2.5 days versus control group (p = 0.044). Conclusions: The addition of L. fermentum CECT5716 Lc40 or B. breve CECT7263, two probiotic strains naturally found in breast milk, to infant formulae is safe and induces beneficial effects on the health of infants.
URI: http://hdl.handle.net/10668/3129
Versión del editor : https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-019-1753-7
DOI: 10.1186/s12887-019-1753-7
ISSN : 1471-2431 (Online)
Appears in Collections:01- Artículos - Servicio Andaluz de Salud
01- Artículos - ibsGRANADA. Instituto de Investigación Biosanitaria de Granada
01- Artículos - ibsGRANADA. Instituto de Investigación Biosanitaria de Granada
01- Artículos - Hospital Virgen de las Nieves
01- Artículos - IMIBIC. Instituto Maimónides de Investigación Biomédica de Córdoba

Files in This Item:
File Description SizeFormat 
Maldonado_EvaluationOfTheSafety.pdfArtículo publicado1,43 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons